129 related articles for article (PubMed ID: 37973326)
1. People who inject drugs: testing and treatment of HIV and HCV.
Sarker MS
Lancet Glob Health; 2023 Dec; 11(12):e1832-e1833. PubMed ID: 37973326
[No Abstract] [Full Text] [Related]
2. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
[TBL] [Abstract][Full Text] [Related]
3. Time for a New Approach to Guidance for Human Immunodeficiency Virus and Hepatitis C Virus Testing Among Persons Who Inject Drugs.
Linas BP
J Infect Dis; 2020 Aug; 222(6):885-887. PubMed ID: 32002538
[No Abstract] [Full Text] [Related]
4. Barriers to HIV and Hepatitis C care for people who inject drugs in Colombia.
Borda JP; Friedman HL; Castaño GA; Rodríguez HA; Muñoz CF; Tofighi B
AIDS Care; 2022 May; 34(5):633-638. PubMed ID: 33615915
[TBL] [Abstract][Full Text] [Related]
5. M
Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
[TBL] [Abstract][Full Text] [Related]
6. HIV and HCV testing at clinical encounters among people who inject drugs, 2013-2018-Opportunities for increased testing and prevention.
Evans KN; Vettese T; Wortley PM; Gandhi AP; Bradley H
J Viral Hepat; 2023 Nov; 30(11):848-858. PubMed ID: 37726974
[TBL] [Abstract][Full Text] [Related]
7. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
8. Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis.
Greenwald ZR; Bouck Z; McLean E; Mason K; Lettner B; Broad J; Dodd Z; Nassau T; Scheim AI; Werb D
J Viral Hepat; 2023 Feb; 30(2):160-171. PubMed ID: 36461705
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users.
Hsu JT; Hsu PI; Shie CB; Chuah SK; Wu IT; Huang WW; Tang SY; Tsai KF; Kuo LF; Ghose S; Hsu JC; Shih CA
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334612
[TBL] [Abstract][Full Text] [Related]
10. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
[TBL] [Abstract][Full Text] [Related]
11. Management of HCV and HIV infections among people who inject drugs.
Grebely J; Tyndall MW
Curr Opin HIV AIDS; 2011 Nov; 6(6):501-7. PubMed ID: 22001894
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
Ozga JE; Syvertsen JL; Pollini RA
J Viral Hepat; 2022 Jul; 29(7):518-528. PubMed ID: 35357738
[TBL] [Abstract][Full Text] [Related]
13. Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya.
Stone J; Fraser H; Walker JG; Mafirakureva N; Mundia B; Cleland C; Bartilol K; Musyoki H; Waruiru W; Ragi A; Bhattacharjee P; Chhun N; Lizcano J; Akiyama MJ; Cherutich P; Wisse E; Kurth A; Luhmann N; Vickerman P
AIDS; 2022 Dec; 36(15):2191-2201. PubMed ID: 36111533
[TBL] [Abstract][Full Text] [Related]
14. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
[TBL] [Abstract][Full Text] [Related]
15. More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study.
Heo M; Pericot-Valverde I; Niu J; Norton BL; Akiyama MJ; Nahvi S; Arnsten JH; Litwin AH
J Viral Hepat; 2023 Feb; 30(2):172-175. PubMed ID: 36197920
[No Abstract] [Full Text] [Related]
16. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ
Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Infection Preceding an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs-Kanawha County, West Virginia, 2019-2021.
Hudson AG; Bonacci RA; Moorman AC; Penley M; Wilson SM; Hoffman JL; Thomasson ER; McClung RP; Bixler D
Clin Infect Dis; 2023 Feb; 76(3):e752-e754. PubMed ID: 35903004
[TBL] [Abstract][Full Text] [Related]
18. A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J;
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891535
[TBL] [Abstract][Full Text] [Related]
19. Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: a pilot study.
Fernàndez-López L; Folch C; Majó X; Gasulla L; Casabona J
AIDS Care; 2016; 28(6):712-6. PubMed ID: 27007000
[TBL] [Abstract][Full Text] [Related]
20. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
